Chiarito Mauro, Stolfo Davide, Villaschi Alessandro, Sartori Samantha, Baldetti Luca, Lombardi Carlo Mario, Adamo Marianna, Loiacono Ferdinando, Sammartino Antonio Maria, Riccardi Mauro, Tomasoni Daniela, Inciardi Riccardo Maria, Maccallini Marta, Gasparini Gaia, Grossi Benedetta, Contessi Stefano, Cocianni Daniele, Perotto Maria, Barone Giuseppe, Merlo Marco, Cappelletti Alberto Maria, Sinagra Gianfranco, Pini Daniela, Metra Marco, Pagnesi Matteo
Humanitas Research Hospital IRCCS, Rozzano, Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Eur J Heart Fail. 2025 Apr;27(4):726-736. doi: 10.1002/ejhf.3585. Epub 2025 Jan 20.
Accurate selection of patients with severe heart failure (HF) who might benefit from advanced therapies is crucial. The present study investigates the performance of the available risk scores aimed at predicting the risk of mortality in patients with severe HF.
The risk of 1-year mortality was estimated in patients with severe HF enrolled in the HELP-HF cohort according to the MAGGIC, 3-CHF, ADHF/NT-proBNP, and GWTG-HF risk scores, the number of criteria of the 2018 HFA-ESC definition of advanced HF, I NEED HELP markers, domains fulfilled of the 2019 HFA-ESC definition of frailty, the frailty index, and the INTERMACS profile. In addition, we tested the performance of different machine learning (ML)-based models to predict 1-year mortality. At 1-year follow-up, 265 patients (23.1%) died. The prognostic accuracy, tested in the subgroup of patients with completeness of all data regarding the variables included in the scores (497/1149 patients), resulted moderate for MAGGIC, GWTG-HF, and ADHF/NT-proBNP scores (area under the curve [AUC] ≥0.70) and only poor for the other tools. All the scores lost accuracy in estimating the rate of 1-year mortality in patients at the highest risk. Support vector machine-based model had the best AUC among ML-based models, slightly outperforming most of the tested risk scores.
Most of the scores used to predict the risk of mortality in HF performed poorly in real-world patients with severe HF and provided inaccurate estimate of the risk of 1-year mortality in patients at the highest risk. ML-based models did not significantly outperform the currently available risk scores and their use must be validated in large cohort of patients.
准确挑选可能从先进治疗中获益的重度心力衰竭(HF)患者至关重要。本研究调查了旨在预测重度HF患者死亡风险的现有风险评分的性能。
根据MAGGIC、3-CHF、ADHF/NT-proBNP和GWTG-HF风险评分、2018年HFA-ESC晚期HF定义的标准数量、“我需要帮助”标志物、2019年HFA-ESC衰弱定义中满足的领域、衰弱指数以及INTERMACS概况,对纳入HELP-HF队列的重度HF患者的1年死亡风险进行了估计。此外,我们测试了不同的基于机器学习(ML)的模型预测1年死亡率的性能。在1年随访时,265例患者(23.1%)死亡。在所有数据关于评分中包含变量均完整的患者亚组(497/1149例患者)中进行测试,MAGGIC、GWTG-HF和ADHF/NT-proBNP评分的预后准确性中等(曲线下面积[AUC]≥0.70),而其他工具的准确性较差。所有评分在估计最高风险患者的1年死亡率时准确性均下降。基于支持向量机的模型在基于ML的模型中AUC最佳,略优于大多数测试的风险评分。
大多数用于预测HF患者死亡风险的评分在现实世界的重度HF患者中表现不佳,并且对最高风险患者的1年死亡风险估计不准确。基于ML的模型并未显著优于当前可用的风险评分,其应用必须在大量患者队列中进行验证。